Search Results - "Minchenko, Zh M"

The role of exosomes in the mechanisms of inflammation development in patients with cardiovascular pathology and the contribution to therapeutic potential of stem cells by Muzychenko, P. F., Minchenko, Zh. M., Havrylenko, T. I., Cherniak, V. A., Demidov, S. V., Ryzhkova, N. O., Pidhaina, O. A.

“…The aim – based on the analysis of the scientific literature focused on understanding the role of exosomes in the mechanisms of inflammation development and…”
Get full text

Calculations of supramolecular structures of peptidylboronic acid (bortezomib) with ABO blood system antigen by Kustovska, A. D., Prymachenko, S. V., Minchenko, Zh. M., Liubarets, T. F., Dmytrenko, O. O.

“…Peptidylboronic acids have recently become widespread as effective drugs for cancer treatment. Howe­ver, the use of these drugs is often accompanied by…”
Get full text

SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES FOR THE OUTCOMES AFTER THE SECOND LINE NILOTINIB THERAPY IN THE CHRONIC MYELOID LEUKEMIA PATIENTS by Dmytrenko, I. V., Minchenko, Zh. M, Fedorenko, V. V., Dyagil, I. S.

“…Background. There is limited information about impact of additional chromosome aberrations (ACA) on the efficacy of the 2nd line nilotinib therapy. Objective…”
Get full text

PROGNOSTIC VALUE OF ADDITIONAL CHROMOSOMAL ABERRATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON TYROSINEKINASE INHIBITORS THERAPY by Dmytrenko, I. V., Minchenko, Zh. M., Fedorenko, V. G., Dyagil, I. S.

“…Prognostic significance of additional chromosomal abnormalities (ACAs) for tyrosinekinase inhibitors therapy (TKI) response in chronic myeloid leukemia (CML)…”
Get full text

BCR/ABL1 KINASE DOMAIN MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA WITH SECONDARY RESISTANCE TO THE IMATINIB THERAPY by Dmytrenko, I. V., Minchenko, Zh. M., Dyagil, I. S.

Get full text

BCR/ABL1 GENE EXPRESSION RATE AT 3 MONTHS OF THYROSINKINASE INHIBITORS THERAPY AS A PROGNOSTIC FACTOR OF THERAPY RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA by Dmytrenko, I. V., Minchenko, Zh. M., Martina, Z. V., Shlyakhtychenko, T. Y., Dmytrenko, O. O., Dyagil, I. S.

Get full text

REVIEW OF THE NATURE OF ANTI/INFLAMMATORY AND PRO-INFLAMMATORY CYTOKINE REGULATION IN DIFFERENT PERIODS OF PLASMA CELL MYELOMA NATURAL HISTORY IN THE CHORNOBYL NPP ACCIDENT SURVIVORS by Minchenko, Zh M, Dmytrenko, O O, Silaiev, Yu O, Liubarets, T F

“…identify the nature of anti-inflammatory and pro-inflammatory cytokine regulation in different periods of plasma cell myeloma (PCM) natural history with…”
Get more information

COMPLEX ANALYSIS OF THE ROLE OF CYTOKINE GENE POLYMORPHISMS AS PROGNOSTIC FACTOR OF THE RISK OF PLASMA CELL MYELOMA IN PERSONS SUFFERED AFTER THE CHORNOBYL NPP ACCIDENT by Minchenko, Zh M, Dmytrenko, O O, Liubarets, T F, Silaev, Yu O, Stroy, D O, Balan, V V, Shlyakhtychenko, T Yu

“…to provide a comparative characterization of the prevalence of polymorphic variants of cytokine genes in plasma cell myeloma (PCM) patients suffered after the…”
Get more information